Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 1]

View source ↗

Summary

This document notes the completion of a Phase 1 clinical trial evaluating a vaccine therapy in patients with stage III or stage IV melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Melanoma (Skin) | Phase 1 | Status: COMPLETED